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ORIGINAL ARTICLE  
DIABETIC KETOACIDOSIS CHARACTERISTICS AND DIFFERENCES 
IN TYPE 1 VERSUS TYPE 2 DIABETES PATIENTS 
Muhammad Owais Rashid, Aisha Sheikh, Abdus Salam, Saad Farooq, Zareen Kiran, 
Najmul Islam 
Aga Khan University Hospital Karachi-Pakistan 
Background: Diabetes is undoubtedly one of the most challenging health problems of the 21st 
century. It is well known that diabetes once develop can lead to several complications. Diabetic 
ketoacidosis (DKA) is one of the life-threatening complications of diabetes. This study was 
designed to determine the frequency of DKA in diabetes patients and find out the clinical and 
biochemical determinants of DKA. Methods: This descriptive study was conducted at Aga Khan 
University Hospital (AKUH) Karachi, Pakistan from January 2010 to February 2016. All known 
or newly diagnosed diabetic patients of >16 years of age irrespective of gender and type of 
diabetes were included. Information regarding patient’s demographics, presenting symptoms, 
precipitating causes of DKA, biochemical profiles and outcome at the time of discharge was 
collected. Results: Majority (54.7%) had moderate and 12.4% had severe DKA at presentation. 
Previous history of DKA was found higher in type 1 diabetes patients (T1DM) (14%) as compare 
to (4%)  type 2 diabetes patients (T2DM) (p<0.05). DKA severity was observed more (12%) in 
newly diagnosed (T1DM) (p<0.05). Comorbidities were found more (81%) in (T2DM) (p<0.05) 
Mortality was also observed higher in Type 2 diabetes patients (p<0.05). Conclusion: Majority of 
the diabetics had moderate to severe DKA at presentation. Mortality and morbidity related with 
DKA was found considerably higher among patients with T2DM while infection, myocardial 
infarction and stroke found as triggering factors in these patients. 
Keywords: Diabetic ketoacidosis (DKA); T1DM; T2DM 
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INTRODUCTION 
Diabetic ketoacidosis (DKA) is a medical emergency 
which was once thought to occur in only type 1 
diabetes patient but has now been proven to occur in 
type 2 diabetes as well. It occurs due to relative or 
complete lack of insulin in the body.1–3 
Its prevalence is higher among type 2 
diabetes mellitus (T2DM) patients as compared to 
type 1 diabetes mellitus (T1DM), and the proportion 
is expected to increase over the next 20 years; 
therefore, the presentation of DKA is likely to be 
higher in people with T2DM.4 The overall prevalence 
of ketosis-prone T2DM is comparatively lower in 
Asian and white people and may represent fewer than 
10% of cases of DKA.5,6 
There are various parameters that need to be 
ascertained in both type 1 and type 2 diabetes patients 
who present with DKA, like age of presentation, 
presenting clinical features, precipitating cause and 
biochemical characteristics. Many studies have been 
conducted to observe the characteristics of DKA in 
both type 1 and type 2 diabetes mellitus2,5,7 and 
various comparisons have been made worldwide but 
the local data of Pakistan is still scarce. The need for 
more studies is needed and justified in order to know 
valuable information about ketoacidosis in Pakistani 
diabetes patients. This information will help in 
increasing our knowledge and understanding of 
various factors related to DKA and help in 
differentiating the various characteristics of both type 
1 and type 2 diabetes patients. In the present study, 
we aimed to determine the frequency of DKA in 
Pakistani diabetes population and comparison of 
clinical and biochemical characteristics of DKA in 
type 1  and type 2 diabetes. 
MATERIAL AND METHODS 
This retrospective study was conducted among 234   
patients aged 16 years and above of either gender 
admitted with diagnosis of DKA to Aga Khan 
University Hospital (AKUH) Karachi, Pakistan 
during the period from January 2010 to February 
2016. Patients aged below 16 years and non-diabetics 
presenting with ketoacidosis were excluded from the 
study. Informed written consent was obtained from 
hospital authorities to use the data of patients. No 
personal detail by any means related to any patient 
was revealed in regard of ethical considerations. 
Computer coding was used to identify 
admissions with an ICD code for DM and DKA 
during the period of study. Diagnosis of DKA was 
made by the presence of an arterial pH lower than 
7.30, an anion gap of less than 15 mmol/L, 
presence of hyperglycemia, i.e., blood glucose 
>250mg/dL, urine ketone levels of ‘moderate’or 
‘large’ i.e., equal to or more than 2+. DKA was 
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classified as mild, moderate or severe according to 
ADA criteria1 (see annexure). Serum osmolality 
was being calculated using the formula 2[measured 
Na (mEq/l)] + glucose (mg/dl)/18 and was 
measured in mosm/kg. Anion gap was calculated 
using the formula (Na+) − (Cl− + HCO3−) 
(mEq/L).  
All patients presenting with DKA were 
admitted under medicine service and were 
managed by team of internist, medicine residents 
and interns while in emergency department and 
ward. Endocrinology team including an 
endocrinologist, fellow endocrinology and diabetes 
nurse were later involved as specialist team. All 
patients were managed as per the hospital’s local 
management protocol of DKA. 
Patients data was reviewed retrospectively 
regarding patient’s demographics, presenting 
symptoms, precipitating causes of DKA, vital 
signs, biochemical profiles at presentation to the 
emergency department, amount of intravenous 
fluid administered, amount of insulin administered, 
duration of insulin infusion, time from presentation 
to resolution of urine ketones, insulin dose at 
discharge, and length of hospitalization and 
outcome at the time of discharge was collected. 
Precipitating factors of DKA were defined as 
conditions leading to the development of DKA, 
such as inadequate insulin dose or missed insulin 
doses, sepsis, infection, surgical stress etc. For 
patient presenting with more than one factor, the 
main cause was noted. Observation bias was 
controlled by reconfirmation of collected 
information from hospital’s records by a second 
verifier. Confounding factors were rectified 
through restriction. 
Subjects were classified as Type 2 DM if 
they had prior history of treatment (>1 years) with 
diet alone or oral hypoglycaemic agents (OHA), or 
as ‘new onset’ if the episode of DKA was the first 
manifestation of diabetes. Patients with new-onset 
DM were further classified as type 1 or type 2 if 
they discontinued insulin use without recurrence of 
DKA for at least 1 year respectively. Patients 
follow-up data was obtained by chart review or 
telephone contact when necessary. 
Data was analysed by using SPSS version 
19.0. Frequency and percentages were computed 
for categorical variables, i.e.; gender, type and 
duration of DM, previous episode of DKA, 
presenting symptoms and severity of DKA. Chi 
square test was used to compare the categorical 
variables between T1DM versus T2DM patients. 
Mean and Standard Deviation was computed for 
continuous variables, i.e.; age, BMI, duration of 
DM and biochemical parameters. T-test and 
ANOVA were used to compare Mean±Standard 
Deviation. P value less than 0.05 was considered 
as significant. 
RESULTS 
Data of 234 patients with diabetes was used in this 
study. Patients were divided into four groups, 
newly diagnosed type I (n=47), known type I 
(n=59), newly diagnosed type II (n=10) and known 
type II (n=118). Out of total 234 patients, 120 
(51.3%) were males and 114 (48.7%) were 
females. Body mass index (BMI) was found 
significantly more in type 2 diabetes (p<0.05). 
Previous history of DKA was found more in 
known type I diabetes patients (14%) as compare 
to (4%) known type II diabetes patients (p<0.05). 
More than half (54.7%) of the subjects had 
moderate DKA and 12.4% of them had severe 
DKA at presentation. DKA severity was observed 
more (12%) in newly diagnosed type 1 diabetes 
patients (p<0.05). Comorbidities were found more 
(81%) in known type 2 diabetes patients (p<0.05) 
(Table-1).  
Table-2 shows the presentation of 
biochemical parameters of the study participants. 
Haemoglobin levels were higher in newly 
diagnosed type 1 diabetes patients (p<0.001). 
WBC and platelet counts were high in known type 
1 diabetes patients (p<0.05).No significant 
differences were found in other biochemical 
parameters. (Table-2) 
Figure-1 shows the presenting symptoms 
of patients of type I and II diabetes. Polyphagia, 
polydipsia, polyuria, weight loss and abdominal 
pain was significantly higher in type 1 diabetes 
patients. 
The comparison of DKA treatment of type 
I and type II patients are presented in Table-3. The 
amount of insulin given to the type 1 and 2 patients 
were same (p>0.05). Length of stay in hospital, ICU 
admission and ventilator support were also not 
different significantly in both groups (p>0.05). 
Precipitating factors like infection, myocardial 
infarction and stroke were found more in type 2 
patients, while more type 1 patients were found non-
compliant (p<0.05). Overall mortality due to DKA  
was 9.4% (22 out of 234 patients) and was higher in 
type 2 patients (p<0.05). Six out of 47 (12.8%) newly 
diagnosed type 1 patients and 16 out of 118 (13.6%) 
known type 2 diabetic patients had mortality due to 
DKA (p<0.05). 
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Figure-1: Presenting symptoms of type 1 and type 2 patients. 
Other included Fits, cough, diarrhoea and nausea. Only moderate and severe altered mental status is presented. 
*p<0.05, **p<0.0001 
Table-1: Baseline characteristics of the study groups 
  Newly diagnosed Type 1 Known type 1 Newly diagnosed Type 2 Known type 2 
Number of patients 47 59 10 118 
Age (years) 31.7±13.2 31.6±12.6 55.6±14.1 57.0±12.3 
Sex     
Male 61.7 (29) 39 (23) 70 (7) 51.7(61) 
Female 38.3(18) 61 (36) 30 (3) 48.3(57) 
Duration of diabetes (years) 0.06±0.44 8.3±7.9 --- 9.9±8.4 
Less than a year 97.9 (46) 3.4 (2) 100 (10) 21.2 (25) 
1-5 years 2.1 (1) 47.5 (28) --- 14.4 (17) 
6-10 years --- 18.6 (11) --- 22 (26) 
>10 years --- 30.5 (18) --- 42.4 (50) 
BMI (kg/m²) 21.3±5.5 22.0±4.3 22.1±1.49 26.7±7.6 
Previous episodes of DKA 0 (0) 23.7 (14) 0 (0) 3.4 (4) 
Severity of DKA     
Mild 21.3 (10) 28.8 (17) 30 (3) 39.8 (47) 
Moderate 53.2 (25) 59.3 (35) 60 (6) 52.5 (62) 
Severe 25.5 (12) 11.9 (7) 10 (1) 7.6 (9) 
Comorbidities 18.8 (9) 28.8(17) 50 (5) 68.6 (81) 
Data presented as Mean±Sd and %(n) 
Table-2: Biochemical characteristics of subgroups of patients with DKA 
  Newly diagnosed 
Type 1 
Known type 1 
diabetes 
Newly diagnosed type 
2 
Known type 2 
diabetes 
Haemoglobin (gm/dl)  13.8±2.5 13.1±1.9 13.5±2.5 11.9±2.5 
WBC Count (x10E9/L)  13.7±7.1 18±8.8 12.7±4.9 16.3±6.7 
Platelet Count (x10E9/L)  256.3±121.9 339.6±143.8 231.6±104 306.8±145.3 
BUN (mg/dl)  23.2±23.6 23.2±17.1 20.8±12.1 40.4±28.2 
Creatinine (mg/dl)  1.7±2.2 1.6±1.4 1.6±0.5 2.3±1.9 
Sodium (mmol/L)  133.4±9 132±7.8 134.2±6.7 130.9±8.8 
Potassium (mmol/L)  4.1±1 4.8±1.2 4.5±0.8 4.9±1.1 
Chloride (mmol/L)  99.3±10.8 97.4±10.4 98.9±6 96.5±9.5 
Bicarbonate (mmol/L)  8.7±4.6 9.8±5.4 10.4±3.5 11.6±4.7 
Arterial pH  7.2±0.2 7.2±0.1 7.2±0.1 7.2±0.1 
PCO2 (mmHg)  22.6±9.4 20.6±7.3 28.6±12.3 25.3±9.3 
PO2 (mmHg)  130.4±81.8 124.3±83 79.1±44.7 120.1±73.7 
O2 Saturation (%)  92.6±12.6 92.2±15.5 80.3±27.1 92.4±11.7 
Amylase  120.5±109.7 291.7±488.8 147.5±38.9 215.1±290.6 
Lipase  155.6±175.2 155.4±282.5 84±22.6 208.2±502.3 
Urinary Ketones  2.7±0.4 2.7±0.5 2.5±0.5 2.4±0.7 
Random Blood Sugar  513.9±210.3 490.6±203.3 517.5±156.8 485.6±176.7 
Serum osmolality (mosm/Kg)  304.4±31.6 303.6±24.5 310.7±29.5 303.5±28.4 
Anion Gap  25.3±6.4 25.5±7.4 24.9±7.1 23.1±7.2 
HBA1C % 12.3±3 11.9±2.8 12.8±2.3 10.7±2.7 
Data presented as Mean±SD 
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Table3: Mode of severity and outcome of DKA in type 1 and type 2 diabetes 
Characteristic  Type 1(n=106) Type 2 (n=128) p-value Total 


















Amount of Insulin (units per hour) 152.4±224.9 141.3±159.8 0.252 146.5±192.8 
Length of stay (days) 5.92±8.8 5.92±5.3 0.106 5.92±7.08 
Admission in ICU 24.5 (26) 30.5 (39) 0.313 27.8 (65) 



























Mortality  5.7 (6) 12.5 (16) 0.013 9.4 (22) 
 
DISCUSSION 
As highlighted earlier the aim of this study was to 
determine the prevalence, mortality and morbidity 
associated with DKA. The finding of this study has 
revealed that all diabetic patients irrespective of type 
of diabetes are at risk of being hospitalized with 
DKA. This finding is supported by similar previous 
study as well.8  
In our study, T1DM was predominantly 
higher among middle aged patients whereas T2DM 
was highly prevalent in older patients (mostly above 
fifty-five years of age). This finding is also supported 
by other studies.8–10 Studies also reported that 
atypical diabetes with ketosis also widely exist 
worldwide.10,11  
The average length of stay in our study was 
6 days. Moreover, there was insignificant difference 
in length of stay of among patients with T1DM and 
T2DM. This finding was found higher when 
compared with a study conducted in USA but lower 
when compared with a study conducted in China.8,12  
Overall mortality was found to be 
considerably higher in our cohort as compared to 
various studies conducted in different regions of the 
world.8,9,13–15 In particular, mortality was 
predominantly higher in patients with T2DM. The 
higher mortality rate in T2DM may be due the reason 
that T2DM is highly prevalent in our region. Most of 
the patients with T2DM presented with multiple 
complications which is supported by the evidence 
that precipitating factors like infections, myocardial 
infection and stroke was significantly higher among 
patients with T2DM. 
It is reported that DKA can be caused when 
patients forget or knowingly do not take diabetic 
medications or they may have developed a secondary 
condition such as infection, myocardial infarction, 
stroke, pancreatitis etc. which results in increased 
demand or insufficient levels of insulin in the body. It 
can also occur when diabetic patients take 
medications such as corticosteroids.1,2 Several 
complications also occurred during the treatment of 
DKA.3,16–21 
CONCLUSION 
Majority of the patients  had moderate to severe DKA 
at presentation. Mortality and morbidity related with 
DKA was found considerably higher among patients 
with T2DM while infection, myocardial infarction 
and stroke found as triggering factors in these 
patients. 
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